RankAlpha logo
Back to Rankings

BON

Bon Natural LifeB
Nasdaq / Materials
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment AI
B+
Bull case
20%
Probability
Target price
$1.90
Analysis reference price unavailable
Analysis 2026-04-16 · RankAlpha Sentiment AI
Most likely
B
Base case
50%
Probability
Target price
$1.30
Analysis reference price unavailable
Analysis 2026-04-16 · RankAlpha Sentiment AI
B-
Bear case
30%
Probability
Target price
$0.70
Analysis reference price unavailable
Analysis 2026-04-16 · RankAlpha Sentiment AI

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-04-16
Recent news sentiment (30D)
+24.3
Positive
Company
-
Unavailable
Macro
+24.3
Positive
Pulse
-
Unavailable
Weekly research (10D)
-24.0
Negative
Sentiment proxy
+71.7
Score

AI commentary

Market coverage and analyst targets are thin; visible consensus clustering around $1.28–$1.36 suggests limited priced upside absent company‑specific milestones [#SERP-3] [#SERP-7]. Recent primary materials (IR/PR) emphasize product launches and cooperation agreements but lack dated milestone disclosures, keeping sentiment cautious and event‑driven [#IR-undated] [#PR-undated].

RankAlpha Sentiment AI - 2026-04-16
Open full AI memo

Evidence flagged

Coverage is limited for this name. This memo is usable, but confidence is lower and evidence depth is thinner than a standard report.

Impact
tentative
Confidence
-

AI events

2026-07-15eventIR/PR updates on product commercialization and contract milestonesHigh impact

Investor‑relations page and press releases indicate planned product launches and cooperation updates; a dated PR/IR update confirming shipment volumes, milestone receipts, or amended contract terms would be a near‑term event to watch [#IR-undated] [#PR-undated].

2027-04-16catalystCommercial rollout and revenue recognition from US$26M cooperation agreementHigh impact

Company disclosed a cooperation agreement (US$26M) tied to next‑gen tea pigment / digestive‑health product cooperation with Beijing Huahai Keyuan; successful commercial rollout / initial revenue recognition would materially de‑risk growth expectations [#IR-undated] [#PR-undated].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-04-16 • Updated nightlySource: Internal modelMethodology